Michael C. Perry - Concepedia

Author

Michael C. Perry

Also Known As

Frank Chingewundoh, M C Perry, M Perry, M. C. PERRY, M. C. Perry, M. Perry, M.C Perry, M.C. Perry, MICHAEL C. PERRY, MICHAEL PERRY

268

Publications

19.4K

Citations

H-Index

240

Concepts

All Affiliations

University of Missouri Dana-Farber Cancer Institute Aston University Cleveland Clinic The University of Texas MD Anderson Cancer Center

About

Michael C. Perry is an author at University of Missouri specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	75	4.5K
2	Health Sciences	16	21	1.6K
3	Engineering	11	11	502
4	Natural Sciences	6	6	263
5	Language Studies	1	1	12

Michael C. Perry

119

Publications

15K

Citations

H-Index

Page 1

	Year	Citations
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer Alan Sandler, Robert J. Gray, Michael C. Perry, New England Journal of Medicine	2006	5.8K
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer Robert O. Dillman, Stephen L. Seagren, Kathleen J. Propert, New England Journal of Medicine	1990	1.2K
Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung Michael C. Perry, Walter L. Eaton, Kathleen J. Propert, New England Journal of Medicine Initial RadiotherapyRadiation MedicineRadiation TherapyMedicineToxic Effects	1987	489
Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730) Rogério Lilenbaum, James E. Herndon, Marcy A. List, Journal of Clinical Oncology	2004	451
A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer Steven M. Keller, Sudeshna Adak, Henry Wagner, New England Journal of Medicine	2000	450
Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431 Everett E. Vokes, James E. Herndon, Jeffrey Crawford, Journal of Clinical Oncology	2002	373
Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial - E4599 Alan B. Sandler, R Gray, Julie R. Brahmer, Journal of Clinical Oncology ImmunologyPathologyLba4 BackgroundOncologyMetronomic Therapy	2005	360
Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342 Eric P. Winer, Donald A. Berry, Susan Woolf, Journal of Clinical Oncology	2004	270
Social support as a buffer to the psychological impact of stressful life events in women with breast cancer Alice B. Kornblith, James E. Herndon, Enid Zuckerman, Cancer	2001	264
Plasma microRNAs as novel biomarkers for early detection of lung cancer. Dali Zheng, Shadi Haddadin, Yong Wang, PubMed EngineeringImmunologyPathologyPlasma MicrornasCancer Detection	2011	262

Page 1